As CEO of HospiceChoice Rx, Nick Opalich brings over 20 years of leadership experience in the healthcare sector. His expertise spans healthcare innovation, specialty drug benefit management, and patient-centered solutions. He is dedicated to optimizing disease management and improving pharmaceutical access for underserved populations.
As a former managing partner at Strategica Health Partners and CEO at InfinityRx, Nick has demonstrated proven experience in collaboration and operational excellence within specialty pharma, including business development and financial modeling.
As CEO at HospiceChoice Rx, Nick is committed to empowering healthcare organizations through strategic partnerships and innovative approaches to reimbursement and patient affordability programs.
